Literature DB >> 32503826

Tor Vergata University-Hospital in the Beginning of COVID-19-Era: Experience and Recommendation for Breast Cancer Patients.

Oreste Claudio Buonomo1, Marco Materazzo1, Marco Pellicciaro1, Jonathan Caspi1, Emilio Piccione2, Gianluca Vanni3.   

Abstract

COVID-19 has been officially declared as a pandemic by the WHO. Italy was the first European country to be strongly affected by this outbreak. All elective and health promotion activities were reduced. Accordingly, Italian Breast Units and breast cancer (BC) screening programs scaled down significantly their activities. The aim of this study was to evaluate measures that could potentially reduce the clinical impact of COVID-19 on BC patients. Temporary recommendations are needed that could assist specialists in preventing COVID-19 infection and optimizing resources for diagnosis and treatment of BC patients. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Breast cancer; COVID-19; Italy; screening program; tailored treatment

Mesh：

Substances：

Year:  2020        PMID： 32503826     DOI： 10.21873/invivo.11958

Source DB:  PubMed          Journal:  In Vivo        ISSN： 0258-851X            Impact factor:   2.155


  7 in total

Review 1.  The Impact of the SARS-CoV-2 Pandemic on Healthcare Provision in Italy to non-COVID Patients: a Systematic Review.

Authors:  Gianmarco Lugli; Matteo Maria Ottaviani; Annarita Botta; Guido Ascione; Alessandro Bruschi; Federico Cagnazzo; Lorenzo Zammarchi; Paola Romagnani; Tommaso Portaluri
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-01-01       Impact factor: 2.576

2.  Background Parenchymal Enhancement in Contrast-enhanced Spectral Mammography: A Retrospective Analysis and a Pictorial Review of Clinical Cases.

Authors:  Rosaria Meucci; Chiara Adriana Pistolese; Tommaso Perretta; Gianluca Vanni; Emanuela Beninati; Federica DI Tosto; Maria Lina Serio; Aurelia Caliandro; Marco Materazzo; Marco Pellicciaro; Oreste Claudio Buonomo
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

3.  Effect of Lockdown in Surgical Emergency Accesses: Experience of a COVID-19 Hospital.

Authors:  Gianluca Vanni; Jacopo Maria Legramante; Marco Pellicciaro; Gerardo DE Carolis; Maria Cotesta; Marco Materazzo; Chiara Buonomo; Andrea Farinaccio; Francesca Santori; Federica Saraceno; Benedetto Ielpo; Francesco Aiello; Carla Paganelli; Michele Grande; Girolamo DE Andreis; Marcello Chiocchi; Leonardo Palombi; Oreste Claudio Buonomo
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

4.  Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.

Authors:  Gianluca Vanni; Marco Pellicciaro; Marco Materazzo; Valentina Bruno; Chiara Oldani; Chiara Adriana Pistolese; Chiara Buonomo; Jonathan Caspi; Paola Gualtieri; Agostino Chiaravalloti; Leonardo Palombi; Emilio Piccione; Oreste Claudio Buonomo
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

5.  Corneal transplant during COVID-19 pandemic: the Italian Eye Bank national report.

Authors:  Francesco Aiello; Federico Genzano Besso; Giulio Pocobelli; Gabriele Gallo Afflitto; Rossella Anna Maria Colabelli Gisoldi; Carlo Nucci; Diego Ponzin
Journal:  Cell Tissue Bank       Date:  2021-05-24       Impact factor: 1.522

6.  Consequences of the impact of COVID-19 pandemic on breast cancer at a single Italian institution.

Authors:  Daniele Ugo Tari; Rosalinda Santonastaso; Fabio Pinto
Journal:  Explor Target Antitumor Ther       Date:  2022-07-29

7.  Breast Cancer Screening during COVID-19 Emergency: Patients and Department Management in a Local Experience.

Authors:  Francesca Maio; Daniele Ugo Tari; Vincenza Granata; Roberta Fusco; Roberta Grassi; Antonella Petrillo; Fabio Pinto
Journal:  J Pers Med       Date:  2021-05-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.